An inhibitor of the SET-PP2A protein-protein interaction
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MP07-66

Item No. 42337

Technical Information
Formal Name
N-(2,2-diethoxyethyl)-4-(hexyloxy)-benzenemethanamine
CAS Number
1938056-90-6
Molecular Formula
C19H33NO3
Formula Weight
Purity
≥98%
A solution in ethanol
Ethanol: Soluble: ≥10 mg/ml
SMILES
CCCCCCOC(C=C1)=CC=C1CNCC(OCC)OCC
InChi Code
InChI=1S/C19H33NO3/c1-4-7-8-9-14-23-18-12-10-17(11-13-18)15-20-16-19(21-5-2)22-6-3/h10-13,19-20H,4-9,14-16H2,1-3H3
InChi Key
WBCMPXCRPPCZSO-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    MP07-66 is an inhibitor of the protein-protein interaction between SET and protein phosphatase 2A (PP2A) and a derivative of FTY720 (fingolimod; Item No. 11975).1 It increases PP2A activity in isolated human B cell chronic lymphocytic leukemia (B-CLL) cells when used at concentrations of 3 and 8 µM. Unlike FTY720, MP07-66 (8 µM) does not decrease plasma membrane levels of sphingosine-1-phosphate receptor 1 (S1P1) in isolated human B-CLL cells. MP07-66 induces apoptosis in isolated human B-CLL cells when used alone or in combination with dasatinib (Item No. 11498).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zonta, F., Pagano, M.A., Trentin, L., et al. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. Blood 125(24), 3747-3755 (2015).